Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04816214 |
| Title | Study Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy (GEOMETRY-E) |
| Acronym | GEOMETRY-E |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | Kashiwa | Chiba | 277 8577 | Japan | Details | |
| Novartis Investigative Site | Sunto Gun | Shizuoka | 411 8777 | Japan | Details | |
| Novartis Investigative Site | Seoul | 05505 | Korea, Republic of | Details | ||
| Novartis Investigative Site | Singapore | 168583 | Singapore | Details |